logo

Palatin Technologies Inc. (PTN)



Trade PTN now with
  Date
  Headline
2/17/2021 7:33:07 AM Palatin Technologies Q2 Net Loss $10.0 Mln Or $0.04/Shr Vs Loss Of $5.2 Mln Or $0.02/Shr Last Year
2/10/2021 7:32:57 AM Palatin Tech Announces Filing Of International Patent Application Claiming PL9643
12/15/2020 7:01:50 AM Palatin Reports Positive Results From Phase 2 Study Of PL9643 In Patients With Dry Eye Disease
11/17/2020 7:34:31 AM Palatin Technologies Q1 Net Loss $3.9 Mln Or $0.02/Shr Vs Loss Of $4.5 Mln Or $0.02/Shr Last Year
9/28/2020 7:32:11 AM Palatin Technologies Q4 Loss/Shr $0.03 Vs EPS $0.23 Last Year
8/5/2020 7:32:41 AM Palatin Technologie Completes Enrollment Of Phase 2 Study With PL9643 For Dry Eye Disease
7/27/2020 7:01:48 AM Palatin Technologies Mutually Terminates License Agreement With AMAG Pharmaceuticals For Vyleesi
7/8/2020 7:31:55 AM Palatin Technologies Announces Reinitiation Of Enrollment Of Phase 2 Study With PL9643
6/29/2020 7:33:04 AM Palatin Technologies Announces Adjournment Of Annual Meeting Of Stockholders Until July 23, 2020